Trial Profile
Multi-Center Open Label, Non-Comparative Observational Study of Irbesartan-Hydrochlorothiazide in the Treatment of Hypertension in Chinese Population.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2009
Price :
$35
*
At a glance
- Drugs Irbesartan/hydrochlorothiazide (Primary) ; Irbesartan
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Sanofi
- 21 Feb 2009 New trial record